• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 77 of 100
Valeant Pharmaceuticals International Inc. Executives Testify At Senate Hearing On Drug Prices
Finance
Hospitals Say Valeant Isn’t Meeting Its Discount Promise
By Lucinda ShenMay 12, 2016
155292424
Health
Another Major Insurer Is Tying Drug Prices to Health Outcomes
By Sy MukherjeeMay 11, 2016
Squawk Box - Season 20
Finance
Bill Ackman Just Unloaded $800 Million in Shares of This Pharma Firm
By ReutersMay 11, 2016
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
Finance
This Is What Bill Ackman Really Thinks About Valeant’s Outgoing CEO
By Laura LorenzettiMay 10, 2016
Fortune Global Forum 2015
Leadership
Meet Health Care’s Major Spoilers: Theranos, Valeant, and Turing Pharmaceuticals
By Bill GeorgeMay 10, 2016
New England Towns Struggle With Opioid And Heroin Epidemic
Health
OxyContin’s 12-Hour Dosing Claim Attacked In Massive Investigation
By Sy MukherjeeMay 6, 2016
Fortune Brainstorm Tech 2015
Finance
Diabetes ‘Unicorn’ Intarcia Hits Major Milestone
By Dan PrimackMay 6, 2016
The Powerful And Influential Attend Clinton Global Initiative Annual Meeting
Health
Merck CEO: We’re on the Hunt for Deals in 2016
By Sy MukherjeeMay 6, 2016
The headquarters of Valeant Pharmaceuticals International, Inc. stands in Bridgewater Township, U.S., on Wednesday Nov. 04, 2015. Photographer: Michael Nagle/Bloomberg
Health
Valeant Says it Has a New Way to Ensure it Doesn’t Price Gouge So Much
By ReutersMay 6, 2016
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
Health
Sanofi Threatens to Oust Drugmaker Medivation’s Board If It Won’t Talk Merger
By ReutersMay 6, 2016
Inside The Pfizer Inc. Kendall Square Research Facility Ahead Of Earnings Figures
Health
Now It’s Pfizer That Wants to Buy Cancer Drug Maker Medivation
By ReutersMay 4, 2016
Stocks Close Sharply Lower As Oil Prices Continue Decline
Finance
These Biopharma Companies Are the World’s Top Shareholder Value Creators
By Sy MukherjeeMay 3, 2016
172646513
Health
U.S. Approves First Drug for Psychosis Linked to Parkinson’s
By ReutersApril 30, 2016
493534821
Health
Big Pharma Under Pressure to Pay For Drug Take-Back Programs
By Sy MukherjeeApril 30, 2016
A screen displays the share price for pharmaceutical maker AbbVie on the floor of the New York Stock Exchange
Finance
AbbVie Buying Cancer Drug Startup Stemcentrx for $10.2 Billion
By Dan PrimackApril 28, 2016
1...
  • 75
  • 76
  • 77
  • 78
  • 79
...100
Most Popular
Success
Jeff Bezos once gave Eva Longoria and the admiral behind Osama bin Laden's capture $100 million—but she says you don't need wealth to give backplaceholder alt text
By Orianna Rosa RoyleOctober 31, 2026
Economy
If California undid its 'original sin' and matched Texas on taxing property, it would raise more revenue than the billionaire tax, economists sayplaceholder alt text
By Jason MaOctober 31, 2026
Europe
‘It’s only when you see 49-ton trucks in China running on batteries that you realize how serious electrification is’: Octopus Energy CEO Greg Jackson on Europe’s incumbency problemplaceholder alt text
By Kamal AhmedOctober 30, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.